Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-25-056331

Options or other derivatives

  • Chief Executive Officer acquired 345,672 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Brumm Joshua T Chief Executive Officer 2025-12-08 Grant or award · Stock Option (Right to Buy) +345,672 345,672 D
Loading xslF345X05/wk-form4_1765402538.xml…